Found 54 matching trials
Evaluation of Dupilumab in Children With Uncontrolled Asthma PHASE3 Primary Objective:
To evaluate the efficacy of dupilumab in children 6 to ...
Show More Location
Investigational Site Number 840031
Learn More & Join Trial
Effective Study of Live Attenuated Varicella Vaccine to Treat Severe Resistant Psoriasis PHASE4 Immunotherapy was reported in the treatment of psoriasis. Treatment of resi...
Show More Location
Multiple Locations
Learn More & Join Trial
Efficacy and Safety Study of Sirukumab in Patients With Giant Cell Arteritis PHASE3 Sirukumab is a fully human anti-interleukin-6 (IL-6) immunoglobulin G1-kapp...
Show More Location
GSK Investigational Site
Learn More & Join Trial
A Study of 2 Doses of Tetravalent Dengue Vaccine (TDV) in Infants and Toddlers PHASE3 Dengue fever is caused by an infection with the dengue virus. Vaccination w...
Show More Location
Clinica de la Costa Ltda
Learn More & Join Trial
Study Comparing Etanercept (ETN) Against a Placebo for Etanercept on a Background Nonsteroidal Anti Inflammatory Drug (NSAIDs) in the Treatment of Early Spondyloarthritis (SpA) Patients Who do Not Have X-ray Structural Changes PHASE3 This is a two part study. During period one there will be a comparison of E...
Show More Location
Centro Medico Privado de Reumatologia
Learn More & Join Trial
Efficacy and Safety Evaluation of Alirocumab (SAR236553/REGN727) in Patients With Primary Hypercholesterolemia on Stable Atorvastatin Therapy in Japan PHASE2 Alirocumab (SAR236553/REGN727) is a fully human monoclonal antibody that bi...
Show More Location
Investigational Site Number 392002
Learn More & Join Trial
Study of the Efficacy and Safety of Alirocumab (REGN727/SAR236553) in Combination With Other Lipid-modifying Treatment (LMT) (ODYSSEY OPTIONS I) PHASE3 This is a randomized, double-blind, active-comparator, parallel-group study...
Show More Location
Multiple Locations
Learn More & Join Trial
Study of Alirocumab (REGN727/SAR236553) added-on to Rosuvastatin Versus Other Lipid Modifying Treatments (LMT) (ODYSSEY OPTIONS II) PHASE3 To evaluate the reduction of low-density lipoprotein cholesterol (LDL-C) by...
Show More Location
Multiple Locations
Learn More & Join Trial
A Prospective, Multicenter, Study of APF530 (Granisetron) SC for Prevention of CINV in Patients Receiving HEC PHASE3 The primary study objective is to demonstrate the superiority of APF530 500...
Show More Location
Arizona Oncology Associates, PC-HAL
Learn More & Join Trial
BLOC-ICH: Interleukin-1 Receptor Antagonist in Intracerebral Haemorrhage PHASE2 This trial will help inform the development of a new treatment for intracer...
Show More Location
Salford Royal NHS Foundation Trust
Learn More & Join Trial